Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2 (APPL2) is a multifunctional adapter protein characterized by a BAR domain (important in membrane curvature sensing), a central PH domain, and a C-terminal phosphotyrosine-binding (PTB) domain[2]. It binds small GTPases, including Rab5, and interacts with various receptors and signaling proteins to regulate cellular processes such as endosomal trafficking, cell proliferation, F-actin remodeling, and signal transduction[1][2]. In pancreatic β-cells, APPL2 is a critical regulator of glucose-stimulated insulin secretion via modulation of Rac1-mediated actin depolymerization. APPL2 also plays roles in the immune response by influencing phagocytosis and inflammatory signaling pathways, and negatively regulates adiponectin signaling and insulin sensitivity in metabolic tissues[1][2][3]. Genetic alterations or dysregulation of APPL2 activity have been linked to metabolic disorders and rare syndromic diseases, but APPL2 itself is not considered a direct pharmacological target[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2 (APPL2).